Any employee of your organization or its subsidiaries can access the report.

Delivered in pdf format in 24 to 72 hours of purchase.

Comes with 3 months of post-purchase analyst support.

About This Report

Market Snapshot

Market Overview

Scope of the Report

Key Market Trends

Competitive Landscape

Major Players

Table of Contents

Market Snapshot

Study Period:

2016-2024

Base Year:

2018

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

Key Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

The global sleep apnea devices market was valued at USD 5,956.9 million in 2018, and is estimated to be valued at USD 9,193.3 million in 2024, witnessing a CAGR of 7.5%. Few key factors that are driving the market include the increasing incidences of sleep apnea, increasing awareness among the patient population in developing countries, and favorable government initiatives.

According to the Sleep Apnea Organization, in 2017, more than 22 million Americans suffered from sleep apnea and 80% of moderate to severe sleep apnea cases were undiagnosed; worldwide, over 100 million people suffer from sleep apnea. Thus, the increasing incidence of sleep apnea is one of the factors responsible for the growth of the sleep apnea devices market.

It is known that obstructive sleep apnea (OSA) is a prevalent condition, which affects up to 20% of the world population. It is a serious and life-threatening sleep illness that is largely undiagnosed and untreated. However, various government initiatives are helping patients who suffer from OSA. For instance, in the United States, the American Sleep Apnea Association (ASAA) was founded in 1990, which is a non-profit organization that promotes awareness regarding sleep apnea, works for continuing improvements in treatments for this serious disorder, and advocates for the interests of sleep apnea patients. All these factors are boosting the market.

Scope of the Report

Sleep apnea is a serious sleep disorder, in which breathing repeatedly stops and starts. There are three main types of sleep apnea, obstructive sleep apnea, central sleep apnea, and complex sleep apnea syndrome. The factors, such as increased incidences of sleep apnea, increasing awareness among the patient population in the developing countries, favorable government initiatives, and upcoming technological advancements, are expected to drive the growth of the market over the forecast period.

By Diagnostic Devices

Polysomnography Devices (PSG)

Pulse Oximeters

Actigraphy Devices

By Therapeutic Devices

Positive Airway Pressure (PAP) Devices

Continuous Positive Airway Pressure (CPAP) Devices

Bi-level Positive Airway Pressure (BiPAP) Devices

Oxygen Devices

Oxygen Concentrators

Portable Oxygen Concentrators

Liquid Portable Oxygen

Oral Appliances

Adaptive Servo Ventilation (ASV) Devices

Masks and Accessories

Geography

North America

United States

Canada

Mexico

Europe

Germany

United Kingdom

France

Italy

Spain

Rest of Europe

Asia-Pacific

China

Japan

India

Australia

South Korea

Rest of Asia-Pacific

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

GCC

South Africa

Rest of Middle East & Africa

Report scope can be customized per your requirements. Click here.

Key Market Trends

Actigraphy Devices is Expected to Grow with Highest CAGR in the Diagnostic Devices Category

Actigraphy devices (actometer or actimeter) utilize a portable device, which is usually worn on the wrist that records physical movement over an extended period. This technology is being increasingly adopted in clinical settings, as actigraphy has the advantage of providing objective information on the sleep habits in patients' natural sleep environment.

Since actigraphy is less invasive and less expensive than the PSG devices, it is a promising device for assessing sleep apnea treatment effects. It also can be used for follow-up, once the treatment has begun or to evaluate changes in sleep, over the course of the treatment period. The rising demand for actigraphy devices in sleep apnea is due to its cost effectiveness, as it facilitates non-intrusive 24-hours monitoring at home for extended periods. The sleep-wake is relatively easy and it does not require any installation.

To understand key trends, Download Sample Report

North America Dominates the Market and Expected to continue its Dominance through the Forecast Period

North America currently dominates the market for sleep apnea devices and is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future, owing to the high incidence of sleep-disordered breathing (SDB) and rising aging population in the region. The United States holds the majority of the market in the North American region. According to the American Sleep Association, as of 2018, it was estimated that about 50-70 million adult population in the United States were found to have a sleep disorder, 48% were reported to be snoring, 37.9% were reported to be falling asleep during the day, unintentionally, and 4.7% were reported to be nodding off while driving. Insomnia is the most common specific sleep disorder, with short-term issues reported by about 30% of adults and chronic insomnia by 10%. Approximately 25 million adults in the United States have obstructive sleep apnea.

According to Sleep Zone, it was estimated that about 22 million Americans suffer from moderate to severe sleep apnea, out of which, approximately 3-7% of men and 2-5% of women were found to have had sleep apnea in 2018 in the United States.

To understand geography trends, Download Sample Report

Competitive Landscape

The sleep apnea devices market is highly competitive and consists of several major player, across the world. Further, with rising technological advancements and product innovations, mid-size and small scale companies are increasing their market presence by introducing new devices into the market with competitive prices. Companies, like Resmed, Fisher & Paykel Healthcare Limited, and Invacare Corporation, hold substantial shares in the market.